A. Isenberg and D. , Systemic lupus erythematosus, This scholarly review summarizes the current knowledge on the pathophysiology of systemic lupus erythematosus, pp.929-939, 2008.

D. Perry, A. Sang, and Y. Yin, Murine Models of Systemic Lupus Erythematosus, Journal of Biomedicine and Biotechnology, vol.180, issue.1, p.271694, 2011.
DOI : 10.1073/pnas.0505539102

E. Sobel, M. Satoh, and Y. Chen, The Major Murine Systemic Lupus Erythematosus Susceptibility Locus Sle1 Results in Abnormal Functions of Both B and T Cells, The Journal of Immunology, vol.169, issue.5, pp.2694-2700, 2002.
DOI : 10.4049/jimmunol.169.5.2694

O. Chan, M. Madaio, and M. Shlomchik, The central and multiple roles of B cells in lupus pathogenesis, Immunological Reviews, vol.131, issue.1, pp.107-121, 1999.
DOI : 10.1084/jem.181.2.641

P. Lipsky, Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity, Nature Immunology, vol.19, issue.9, pp.764-766, 2001.
DOI : 10.1038/ni0901-764

I. Calero and I. Sanz, Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning, Discov Med, vol.10, pp.416-424

S. Navarra, R. Guzman, and A. Gallacher, Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial, The Lancet, vol.377, issue.9767, pp.721-731, 2011.
DOI : 10.1016/S0140-6736(10)61354-2

R. Looney, B Cell-Targeted Therapies for Systemic Lupus Erythematosus, Drugs, vol.56, issue.12, pp.529-540, 2010.
DOI : 10.2165/11535420-000000000-00000

A. Davidson and . Targeting, Targeting BAFF in autoimmunity, Current Opinion in Immunology, vol.22, issue.6, pp.732-739, 2010.
DOI : 10.1016/j.coi.2010.09.010

S. Peng, S. Szabo, and L. Glimcher, T-bet regulates IgG class switching and pathogenic autoantibody production, Proceedings of the National Academy of Sciences, vol.99, issue.8, pp.5545-5550, 2002.
DOI : 10.1073/pnas.082114899

A. Mangini, R. Lafyatis, V. Seventer, and J. , Type I Interferons Inhibition of Inflammatory T Helper Cell Responses in Systemic Lupus Erythematosus, Annals of the New York Academy of Sciences, vol.166, issue.1, pp.11-23, 2007.
DOI : 10.1038/ni1261

N. Charles, D. Hardwick, and E. Daugas, Basophils and the T helper 2 environment can promote the development of lupus nephritis, Nature Medicine, vol.79, issue.6, pp.701-707, 2010.
DOI : 10.1038/nm.2159

L. Ronnblom and V. Pascual, The innate immune system in SLE: type I interferons and dendritic cells, Lupus, vol.9, issue.5, pp.394-399, 2008.
DOI : 10.1177/0961203308090020

C. Monk, M. Spachidou, and F. Rovis, MRL/Mp CD4+,CD25? T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: A novel defect of T cell regulation in systemic lupus erythematosus, Arthritis & Rheumatism, vol.173, issue.4, pp.1180-1184, 2005.
DOI : 10.1002/art.20976

M. Miyara, Z. Amoura, and C. Parizot, Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus, The Journal of Immunology, vol.175, issue.12, pp.8392-8400, 2005.
DOI : 10.4049/jimmunol.175.12.8392

S. Nagpal, P. Sriramarao, and P. Krishnaswamy, Demonstration of IgE Antibodies to Nucleic Acid Antigens in Patients with Sle, Autoimmunity, vol.33, issue.1, pp.59-64, 1990.
DOI : 10.3109/08916939008998433

H. Permin and A. Wiik, THE PREVALENCE OF IgE ANTINUCLEAR ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS, Acta Pathologica Microbiologica Scandinavica Section C Immunology, vol.56, issue.1-6, pp.245-249, 1978.
DOI : 10.1111/j.1699-0463.1978.tb02587.x

A. Atta, C. Sousa, and E. Carvalho, Immunoglobulin E and systemic lupus erythematosus, Brazilian Journal of Medical and Biological Research, vol.37, issue.10, pp.1497-1501, 2004.
DOI : 10.1590/S0100-879X2004001000008

V. Oxelius, Immunoglobulin G (IgG) subclasses and human disease, The American Journal of Medicine, vol.76, issue.3, pp.7-18, 1984.
DOI : 10.1016/0002-9343(84)90314-0

S. Kingsmore, J. Thompson, and A. Crockard, Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus, J Clin Lab Immunol, vol.30, pp.45-52, 1989.

O. Elkayam, R. Tamir, and A. Pick, Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus, Allergy, vol.50, pp.94-96, 1995.

J. Sequeira, D. Cesic, and G. Keser, Allergic Disorders in Systemic Lupus Erythematosus, Lupus, vol.2, issue.3, pp.187-191, 1993.
DOI : 10.1177/096120339300200311

A. Wozniacka, A. Sysa-jedrzejowska, and E. Robak, Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients, Mediators of Inflammation, vol.12, issue.2, pp.95-99, 2003.
DOI : 10.1080/0962935031000097709

I. Sekigawa, T. Yoshiike, and N. Iida, Allergic diseases in systemic lupus erythematosus: prevalence and immunological considerations, Clin Exp Rheumatol, vol.21, pp.117-121, 2003.

H. Mukai, K. Obata, and K. , Nonredundant roles of basophils in immunity This comprehensive review describes the latest advances on basophil biology. The review focuses both on the tools available for studies of mouse basophils and the newly described roles of basophils in health and disease, Annu Rev Immunol Nat Immunol, vol.29, issue.9, pp.45-69733, 2008.

K. Oh, T. Shen, L. Gros, and G. , Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils, Blood, vol.109, pp.2921-2927, 2007.
DOI : 10.1182/blood-2006-07-037739

S. Hida, M. Tadachi, and T. Saito, Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance, Blood, vol.106, issue.6, pp.2011-2017, 2005.
DOI : 10.1182/blood-2005-04-1344

C. Sokol, G. Barton, and A. Farr, A mechanism for the initiation of allergen-induced T helper type 2 responses, Nature Immunology, vol.444, issue.3, pp.310-318, 2008.
DOI : 10.1038/ni1558

N. Charles, W. Watford, and H. Ramos, Lyn Kinase Controls Basophil GATA-3 Transcription Factor Expression and Induction of Th2 Cell Differentiation, Immunity, vol.30, issue.4, pp.533-543, 2009.
DOI : 10.1016/j.immuni.2009.02.008

T. Yoshimoto, K. Yasuda, and H. Tanaka, Basophils contribute to TH2-IgE responses in vivo via IL-4 production and presentation of peptide???MHC class II complexes to CD4+ T cells, Nature Immunology, vol.197, issue.7, pp.706-712, 2009.
DOI : 10.1038/ni.1737

C. Sokol, N. Chu, and S. Yu, Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response, Nature Immunology, vol.111, issue.7, pp.713-720, 2009.
DOI : 10.1038/ni.1738

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252751

R. Gomez, M. Talke, Y. Goebel, and N. , Basophils Support the Survival of Plasma Cells in Mice, The Journal of Immunology, vol.185, issue.12, pp.7180-7185, 2010.
DOI : 10.4049/jimmunol.1002319

K. Mukai, K. Matsuoka, and C. Taya, Basophils Play a Critical Role in the Development of IgE-Mediated Chronic Allergic Inflammation Independently of T Cells and Mast Cells, Immunity, vol.23, issue.2, pp.191-202, 2005.
DOI : 10.1016/j.immuni.2005.06.011

C. Ohnmacht, C. Schwartz, and M. Panzer, Basophils Orchestrate Chronic Allergic Dermatitis and Protective Immunity against Helminths, Immunity, vol.33, issue.3, pp.364-374, 2010.
DOI : 10.1016/j.immuni.2010.08.011

@. Tang, H. Cao, W. Kasturi, and S. , The T helper type 2 response to cysteine proteases requires dendritic cell???basophil cooperation via ROS-mediated signaling, Nature Immunology, vol.173, issue.7, pp.608-617, 2010.
DOI : 10.1016/j.vaccine.2009.03.069

URL : https://hal.archives-ouvertes.fr/hal-00553489

&. Charles and . Rivera, This article reconciles the role of dendritic cells and basophils in the induction of papaïn-induced Th2 responses by demonstrating their collaboration

M. Hibbs and K. Harder, The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling, Growth Factors, vol.31, issue.2, pp.137-149, 2006.
DOI : 10.1084/jem.20041247

Y. Yamanashi, S. Mori, and M. Yoshida, Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I., Proceedings of the National Academy of Sciences, vol.86, issue.17, pp.6538-6542, 1989.
DOI : 10.1073/pnas.86.17.6538

A. Defranco, V. Chan, and C. Lowell, Positive and negative roles of the tyrosine kinase Lyn in B cell function, Seminars in Immunology, vol.10, issue.4, pp.299-307, 1998.
DOI : 10.1006/smim.1998.0122

M. Janas, P. Hodgkin, and M. Hibbs, Genetic evidence for Lyn as a negative regulator of IL-4 signaling, J Immunol, vol.163, pp.4192-4198, 1999.

J. Wang, T. Koizumi, and T. Watanabe, Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice, Journal of Experimental Medicine, vol.184, issue.3, pp.831-838, 1996.
DOI : 10.1084/jem.184.3.831

V. Parravicini, M. Gadina, and M. Kovarova, Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation, Nature Immunology, vol.3, pp.741-748, 2002.
DOI : 10.1038/ni817

S. Odom, G. Gomez, and M. Kovarova, Negative Regulation of Immunoglobulin E???dependent Allergic Responses by Lyn Kinase, The Journal of Experimental Medicine, vol.159, issue.11, pp.1491-1502, 2004.
DOI : 10.4049/jimmunol.167.5.2469

Y. Yamashita, N. Charles, and Y. Furumoto, Cutting Edge: Genetic Variation Influences Fc??RI-Induced Mast Cell Activation and Allergic Responses, The Journal of Immunology, vol.179, issue.2, pp.740-743, 2007.
DOI : 10.4049/jimmunol.179.2.740

C. Baran, S. Tridandapani, and C. Helgason, The Inositol 5???-Phosphatase SHIP-1 and the Src Kinase Lyn Negatively Regulate Macrophage Colony-stimulating Factor-induced Akt Activity, Journal of Biological Chemistry, vol.278, issue.40, pp.38628-38636, 2003.
DOI : 10.1074/jbc.M305021200

K. Harder, L. Parsons, and J. Armes, Gain- and Loss-of-Function Lyn Mutant Mice Define a Critical Inhibitory Role for Lyn in the Myeloid Lineage, Immunity, vol.15, issue.4, pp.603-615, 2001.
DOI : 10.1016/S1074-7613(01)00208-4

M. Hibbs, D. Tarlinton, and J. Armes, Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease, Cell, vol.83, issue.2, pp.301-311, 1995.
DOI : 10.1016/0092-8674(95)90171-X

H. Nishizumi, I. Taniuchi, and Y. Yamanashi, Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice al. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus, Immunity Arthritis Rheum, vol.3, issue.52, pp.549-5603955, 1995.

@. Lu, R. Vidal, G. Kelly, and J. , Genetic associations of LYN with systemic lupus erythematosus, Genes and Immunity, vol.305, issue.5, pp.397-403, 2009.
DOI : 10.1038/ng1847

E. Eiseman and J. Bolen, Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases, Nature, vol.355, issue.6355, pp.78-80, 1992.
DOI : 10.1038/355078a0

S. Beavitt, K. Harder, and J. Kemp, Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity, The Journal of Immunology, vol.175, issue.3, pp.1867-1875, 2005.
DOI : 10.4049/jimmunol.175.3.1867

V. Hernandez-hansen, A. Smith, and Z. Surviladze, Dysregulated Fc??RI Signaling and Altered Fyn and SHIP Activities in Lyn-Deficient Mast Cells, The Journal of Immunology, vol.173, issue.1, pp.100-112, 2004.
DOI : 10.4049/jimmunol.173.1.100

J. Damen, M. Ware, and J. Kalesnikoff, SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation, Blood, vol.97, issue.5, pp.1343-1351, 2001.
DOI : 10.1182/blood.V97.5.1343

C. Harding, Cellular and Molecular Aspects of Antigen Processing and the Function of Class II MHC Molecules, American Journal of Respiratory Cell and Molecular Biology, vol.8, issue.5, pp.461-467, 1993.
DOI : 10.1165/ajrcmb/8.5.461

@. Chen, K. Xu, W. Wilson, and M. , Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell???stimulating programs in basophils, This article describes the involvement of basophils in chronic inflammatory diseases via the binding of IgD, allowing the basophils to boost the immune surveillance, pp.889-898, 2009.
DOI : 10.1038/ni.1748

S. Holgate, R. Buhl, and J. Bousquet, The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update, Respiratory Medicine, vol.103, issue.8, pp.1098-1113, 2009.
DOI : 10.1016/j.rmed.2009.03.008

M. Ben-shoshan, Omalizumab: not only for asthma. Recent Pat Inflamm Allergy Drug Discov, pp.191-201, 2008.